International Clinical Trial: A 12-week, randomized, double-blind, placebo-controlled, parallel-design human clinical trial to evaluate the efficacy and safety of Centella asiatica extract powder for skin improvement

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (KCT0011582) titled 'A 12-week, randomized, double-blind, placebo-controlled, parallel-design human clinical trial to evaluate the efficacy and safety of Centella asiatica extract powder for skin improvement' on Feb. 6.

Study Type: Interventional Study

Study Design: Primary Purpose : Other(Health Promotion), Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT

Primary Sponsor: DERMAPRO

Condition:

Not Applicable

Intervention: Dietary Supplement : The investigational product in this clinical trial is orally administered once daily (one tablet per dose) with water for 12 w...